featured
Relationship of C-Reactive Protein Reduction to Cardiovascular Event Reduction Following Treatment With Canakinumab
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
The Lancet
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Relationship of C-Reactive Protein Reduction to Cardiovascular Event Reduction Following Treatment With Canakinumab: A Secondary Analysis From the CANTOS Randomised Controlled Trial
Lancet 2017 Nov 13;[EPub Ahead of Print], PM Ridker, JG MacFadyen, BM Everett, P Libby, T Thuren, RJ Glynn,From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.